http://rdf.ncbi.nlm.nih.gov/pubchem/patent/RU-2460517-C1

Outgoing Links

Predicate Object
assignee http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_6d498030a69715d035a4d4c41221c829
classificationIPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P27-06
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K9-127
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-726
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-683
filingDate 2011-07-14-04:00^^<http://www.w3.org/2001/XMLSchema#date>
grantDate 2012-09-10-04:00^^<http://www.w3.org/2001/XMLSchema#date>
inventor http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_27bfe999d0b4e8bfc36a45792f83a0c7
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_685d698f466a3ec5914a4037ecfe6877
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_285f0e6f5108e709c4890a28b90bcd6d
publicationDate 2012-09-10-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationNumber RU-2460517-C1
titleOfInvention Pharmaceutical composition for integrated treatment of ocular surface diseases in patients suffering primary open-angle glaucoma
abstract FIELD: medicine. n SUBSTANCE: invention refers to pharmacology and represents a pharmaceutical composition for integrated treatment of ocular surface diseases in the patients suffering primary open-angle glaucoma, on the basis of phospholipids and sulphated glycosaminoglycans, differing by the fact that composition represents a liposomal emulsion formed by phospholipids in the form of liposomes, of average particle size 0.05-0.22 mcm, and sulphated glycosaminoglycans with sulphated glycosaminoglycans presented by keratan sulphate sodium salt and chondroitin sulphate sodium salt with the ingredients of the composition taken in certain proportions, wt %. n EFFECT: invention provides preventing lachrymal production from decreasing, reducing tear evaporation, as well as avoiding pathological changes in conjunctival and corneal epithelial cells. n 5 ex
priorityDate 2011-07-14-04:00^^<http://www.w3.org/2001/XMLSchema#date>
type http://data.epo.org/linked-data/def/patent/Publication

Incoming Links

Predicate Subject
isCitedBy http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-4914088-A
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/RU-2398566-C2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/RU-2302231-C1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/EP-1567125-B1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/RU-2407531-C2
isDiscussedBy http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID415968197
http://rdf.ncbi.nlm.nih.gov/pubchem/protein/ACCO01945
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID449005
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID53477714
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID45357307
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID448670727
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID446715
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID6992100
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID451816491
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID423325378
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID423387664
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419485097
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID24766
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID449761729
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID415712569
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419566218
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID46931058
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID24436
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419554054
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID163606
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID5234

Total number of triples: 42.